Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 1 (ANKRD1 or Cardiac ankyrin repeat protein/CARP) is a cardiac- and skeletal muscle-enriched protein belonging to the muscle ankyrin repeat protein family[1][3][6]. It contains five tandem ankyrin repeats and plays key roles in transcriptional regulation, assembly of the sarcomere (the basic contractile unit of muscle), and mechanosensing of cardiac stress signals[1][3][6]. ANKRD1 acts as a nuclear transcription factor that negatively regulates cardiac gene expression, and is highly induced by cardiac stress and in various cardiomyopathies and heart failure states[1][3][5][6]. Its levels and activity are implicated in the pathogenesis of several heart and muscle diseases, and it is being explored as a sensitive and specific biomarker for certain cardiac and muscle diseases, as well as for predicting chemotherapy outcomes in ovarian cancer[3]. No direct modulating drugs are currently listed, and mechanisms of action for drug-target interactions are not established in available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 1 (ANKRD1).